Tarceva and malignant neoplasm progression Patient Reports February 12, 2012

Tarceva Side Effects Report #6108586-6
Tarceva side effect was reported by a Physician from SWITZERLAND on Feb 18, 2009. Female patient, 41 years of age, was diagnosed with uterine leiomyosarcoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: acute abdomen, asthenia, diarrhoea, fall , femoral neck fracture, malignant neoplasm progression, pathological fracture, pyrexia, sarcoma. Tarceva dosage: unknown. During the same period patient was treated with IBUPROFEN, FRAGMIN, ROCEPHIN, LASIX, NOVALGIN, ISCADOR, XEFO. Patient was hospitalized. Patient died on 12/19/2008.

Tarceva Side Effects Report #5259637-2
Tarceva side effect was reported by a Health Professional from UNITED STATES on Feb 21, 2007. Male patient, 47 years of age, was diagnosed with pancreatic carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cardiac failure congestive, malignant neoplasm progression. Tarceva dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient died.

Tarceva Side Effects Report #5067951-9
Tarceva side effect was reported by a Physician from UNITED STATES on Feb 27, 2006. Male patient was diagnosed with pancreatic carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma metastatic. Tarceva dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient died on 02/27/2006.

Tarceva Side Effects Report #5068742-5
Tarceva side effect was reported by a Physician from UNITED STATES on Nov 04, 2005. Female patient was diagnosed with pancreatic carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma metastatic. Tarceva dosage: unknown. Patient died.


Tarceva Side Effects Report #5074866-9
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2006. Male patient was diagnosed with pancreatic carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma. Tarceva dosage: unknown. Patient died on 11/01/2005.

Tarceva Side Effects Report #5897693-9
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Sept 08, 2008. Female patient was diagnosed with pancreatic carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: intestinal obstruction, malignant neoplasm progression. Tarceva dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #5705085-8
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Mar 27, 2008. Female patient was diagnosed with non-small cell lung cancer recurrent and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cough, dyspnoea, haematocrit decreased, lymphocyte count decreased, malignant neoplasm progression, neutrophil count increased, pleural effusion, pneumonitis, pulmonary fibrosis . Tarceva dosage: (150 MG, QD), ORAL. During the same period patient was treated with LORAZEPAM, ALBUTEROL, PREDNISONE, CARAFATE, OMEPRAZOLE, LEVOTHYROXINE, GABAPENTIN, PENTOXIFYLLINE. Patient was hospitalized. Patient died on 03/27/2008.

Tarceva Side Effects Report #4719233-X
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2005. Male patient, 89 years of age, weighting 114.0 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: asthenia, dysphagia, hypercalcaemia, impaired self-care, malignant neoplasm progression, pain . Tarceva dosage: 150 MG, QD, PO. Patient died on 05/27/2005.

Tarceva Side Effects Report #4899504-7
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2005. Female patient, 88 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: dyspnoea, malignant neoplasm progression, vomiting. Tarceva dosage: 100 MG (QD), ORAL. Patient was hospitalized. Patient recovered.


Tarceva Side Effects Report #5381823-1
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Female patient, 85 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: abdominal pain , fall , malignant neoplasm progression, oedema peripheral, rash , subarachnoid haemorrhage. Tarceva dosage: 100 MG QD, ORAL. During the same period patient was treated with PROTONIX, NORVASC, RASAGILINE, LASIX, MEMANTINE, CLINDAMYCIN OINTMENT. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #4696758-7
Tarceva side effect was reported by a Physician from on June 03, 2005. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: dyspnoea, ejection fraction decreased, fatigue, hypotension, lymphangiosis carcinomatosa, malignant neoplasm progression, pulmonary hypertension , rash , white blood cell count increased. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 06/01/2005.

Tarceva Side Effects Report #4855485-3
Tarceva side effect was reported by a Health Professional from UNITED STATES on Dec 01, 2005. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: abasia, alanine aminotransferase increased, aspartate aminotransferase increased, malignant neoplasm progression, non-small cell lung cancer, rhabdomyolysis. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with SIMVASTATIN, METFORMIN, DYAZIDE, ASPIRIN, MEGACE, LEXAPRO, NADOLOL. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #6060237-5
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Jan 16, 2009. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, hepatic neoplasm, malignant neoplasm progression, pyrexia. Tarceva dosage: 150 MG, QD, ORAL. During the same period patient was treated with THYMOPENTIN, XIHUANG WAN, YUNNAN BAIYAO. Patient recovered.

Tarceva Side Effects Report #6120263-4
Tarceva side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2009. Male patient, 74 years of age, weighting 230.0 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cardiac arrest , diarrhoea, fall , fluid overload, malignant neoplasm progression, nausea , no therapeutic response, renal failure. Tarceva dosage: 100 MG, QD, ORAL. During the same period patient was treated with LIPITOR, TAXOTERE, STEROIDS. Patient was hospitalized. Patient died on 02/09/2009.


Tarceva Side Effects Report #6137406-9
Tarceva side effect was reported by a Health Professional from UNITED STATES on Mar 11, 2009. Male patient, 74 years of age, weighting 230.0 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cardiac arrest , diarrhoea, electrolyte imbalance, fall , fluid overload, malignant neoplasm progression, nausea , renal failure. Tarceva dosage: 100 MG, QD, ORAL. During the same period patient was treated with LIPITOR, TAXOTERE, STEROIDS. Patient was hospitalized. Patient died on 02/09/2009.

Tarceva Side Effects Report #4775460-7
Tarceva side effect was reported by a Health Professional from UNITED STATES on Sept 21, 2005. Female patient, 74 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: malignant melanoma in situ, malignant neoplasm progression, non-small cell lung cancer, rash . Tarceva dosage: 150 MG QD. Patient recovered.

Tarceva Side Effects Report #6051234-4
Tarceva side effect was reported by a Health Professional from UNITED KINGDOM on Jan 05, 2009. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: abdominal discomfort, condition aggravated, corneal perforation, depression , dyspepsia, fungal infection , hypokinesia, malignant neoplasm progression. Tarceva dosage: (100 MG, QD), ORAL. During the same period patient was treated with ZOPICLONE, LOFERPRAMINE, DIAZEPAM, LANSOPRAZOLE. Patient recovered.

Tarceva Side Effects Report #5067873-3
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2005. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with LOVENOX, WARFARIN, APPETITE ENHANCER. Patient died on 10/29/2005.

Tarceva Side Effects Report #5068158-1
Tarceva side effect was reported by a Health Professional from UNITED STATES on Feb 23, 2006. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, lung cancer metastatic, malignant neoplasm progression. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with ANTICOAGULANT. Patient died on 01/27/2006.


Tarceva Side Effects Report #4630852-1
Tarceva side effect was reported by a Physician from on Mar 22, 2005. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, malignant neoplasm progression, nasopharyngitis, non-small cell lung cancer. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with MARINOL, OXYCONTIN, MEGACE. Patient died on 02/16/2005.

Tarceva Side Effects Report #4899899-4
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: headache , malignant neoplasm progression, metastases to central nervous system, vision blurred. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPROL, PREDNISONE, DEXAMETHASONE, DILAUDID, METHADONE. Patient recovered.

Tarceva Side Effects Report #4899765-4
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on May 12, 2005. Female patient, 64 years of age, weighting 142.0 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, malignant neoplasm progression, rash , vision blurred. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.

Tarceva Side Effects Report #4749879-4
Tarceva side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, haemoptysis, heparin-induced thrombocytopenia, malignant neoplasm progression, prothrombin time prolonged, pulmonary embolism . Tarceva dosage: 150 MG (QD (HELD 7/22/2005)), ORAL. During the same period patient was treated with ATENOLOL, HYDROCHLOROTHIAZIDE, SINEMET, AMANTADINE, ACETYLSALICYLIC ACID SRT, ZOCOR, ALBUTEROL, CIMETIDINE. Patient was hospitalized. Patient died on 08/04/2005.

Tarceva Side Effects Report #5960473-X
Tarceva side effect was reported by a Consumer or non-health professional from CANADA on Nov 03, 2008. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Tarceva dosage: (150 MG,QD), ORAL. Patient died on 09/24/2008.


Tarceva Side Effects Report #4943536-7
Tarceva side effect was reported by a Physician from UNITED STATES on Feb 22, 2006. Male patient, 62 years of age, weighting 157.0 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: aortic dissection, exercise tolerance decreased, fatigue, hypertension, malignant neoplasm progression, metastases to liver, pain , pleural fibrosis. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with AVASTIN, COREG, CLINDAMYCIN. Patient was hospitalized and became disabled. Patient died.

Tarceva Side Effects Report #5164524-4
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Nov 08, 2006. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: candida sepsis, catheter site pain, deep vein thrombosis , malignant neoplasm progression, neck mass, neuralgia, non-small cell lung cancer, performance status decreased, pleural effusion. Tarceva dosage: unknown. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5186464-7
Tarceva side effect was reported by a Physician from NORWAY on Nov 27, 2006. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: feeding disorder, gait disturbance, lung infiltration, malaise, malignant neoplasm progression, muscle atrophy, muscular weakness, non-small cell lung cancer metastatic, pneumonia bacterial. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with MEDROL, KLEXANE, PARACET, PANTOPRAZOLE. Patient recovered.

Tarceva Side Effects Report #5067865-4
Tarceva side effect was reported by a Physician from UNITED STATES on Apr 13, 2006. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, interstitial lung disease, malignant neoplasm progression. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with ANTIBIOTICS. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #4989729-4
Tarceva side effect was reported by a Physician from UNITED STATES on Mar 31, 2006. Female patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: gastrointestinal neoplasm, intestinal perforation, malignant neoplasm progression, tumour necrosis. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with DECADRON, NEXIUM. Patient was hospitalized. Patient recovered.


Tarceva Side Effects Report #5176528-6
Tarceva side effect was reported by a Physician from THAILAND on Nov 29, 2006. Female patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, non-small cell lung cancer, rash , retinal haemorrhage. Tarceva dosage: 150 MG (QD), ORAL; SEE IMAGE. During the same period patient was treated with TAXOTERE. Patient recovered.

Tarceva Side Effects Report #5196408-X
Tarceva side effect was reported by a Physician from THAILAND on Dec 11, 2006. Female patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, non-small cell lung cancer, rash , retinal haemorrhage, vision blurred. Tarceva dosage: 150 MG (QD) ORAL. During the same period patient was treated with TAXOTERE. Patient recovered.

Tarceva Side Effects Report #5891568-7
Tarceva side effect was reported by a Physician from BELGIUM on Sept 03, 2008. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: bronchial haemorrhage, haemoglobin decreased, haemoptysis, hepatic infarction, hepatotoxicity, inflammation, malignant neoplasm progression, metastases to liver. Tarceva dosage: (150 MG,QD), ORAL. During the same period patient was treated with AUGMENTIN, ACETAMINOPHEN, ENOXAPARIN, MEDROL, PANTOPRAZOLE, FLUOXETINE, PARASOL, CLONAZEPAM. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #6016566-4
Tarceva side effect was reported by a Physician from CANADA on Dec 04, 2008. Male patient, 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: anaemia, apnoea, cellulitis , depressed mood, malignant neoplasm progression, metastases to lung, pain in extremity. Tarceva dosage: 150 MG, QD, ORAL. Patient died on 09/21/2008.

Tarceva Side Effects Report #4996869-2
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Apr 21, 2006. Female patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: asthenia, cardiac tamponade, dehydration, disease progression, dysphagia, failure to thrive, malignant neoplasm progression, pericardial effusion, pleural effusion. Tarceva dosage: 150MG (QD), ORAL. During the same period patient was treated with ATIVAN, VITAMINS, TRAMADOL, PLAVIX, CELEXA, MEGACE, LIPITOR, RESTORIL. Patient was hospitalized. Patient recovered.


Tarceva Side Effects Report #6094381-3
Tarceva side effect was reported by a Physician from CHINA on Feb 09, 2009. Male patient, 48 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Tarceva dosage: (150 MG, QD), ORAL. Patient recovered.

Tarceva Side Effects Report #4698659-7
Tarceva side effect was reported by a Pharmacist from on June 07, 2005. Female patient, 46 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: anorexia, malignant neoplasm progression, mediastinal disorder, nausea , non-small cell lung cancer metastatic, pneumonia , white blood cell count increased. Tarceva dosage: 150 MG (OD), ORAL. During the same period patient was treated with LOVENOX, PREVACID, ATIVAN, MORPHINE, SONATA, AMOXICILLIN. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5318796-3
Tarceva side effect was reported by a Physician from BELGIUM on Apr 18, 2007. Female patient, 44 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, diarrhoea, gastric disorder, malignant neoplasm progression, non-small cell lung cancer, oesophagitis, purulence. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 02/10/2007.

Tarceva Side Effects Report #5729792-6
Tarceva side effect was reported by a Pharmacist from GERMANY on Apr 17, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: caustic injury, diarrhoea, faeces discoloured, gastritis, malignant neoplasm progression, mucosal inflammation, nausea , non-small cell lung cancer, skin reaction. Tarceva dosage: (150 MG, QD); (100 MG, QD). Patient was hospitalized. Patient died on 04/01/2008.

Tarceva Side Effects Report #5324533-9
Tarceva side effect was reported by a Consumer or non-health professional from ISRAEL on Apr 24, 2007. Female patient, 52 years of age, was diagnosed with neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: balance disorder, coordination abnormal, dizziness , dysarthria, malignant neoplasm progression. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with DANTOIN, DEXAMETHASONE. Patient died on 10/01/2006.


Tarceva Side Effects Report #5515865-X
Tarceva side effect was reported by a Physician from ISRAEL on Oct 26, 2007. Female patient, 52 years of age, was diagnosed with neoplasm malignant, metastases to central nervous system and was treated with Tarceva. After drug was administered, patient experienced the following side effects: ataxia , balance disorder, dizziness , dysarthria, malignant neoplasm progression. Tarceva dosage: (150 MG, QD), ORAL. During the same period patient was treated with PHENYTOIN, DEXAMETHASONE. Patient died on 10/01/2006.

Tarceva Side Effects Report #5068058-7
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 17, 2006. Female patient, 48 years of age, was diagnosed with neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cough, gastrointestinal tube insertion, laryngeal stenosis, malignant neoplasm progression, nasopharyngitis, pneumonia , stomatitis, viral infection , weight decreased. Tarceva dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #5060007-0
Tarceva side effect was reported by a Physician from FRANCE on July 10, 2006. Male patient, 52 years of age, was diagnosed with metastatic bronchial carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, malignant neoplasm progression, metastatic bronchial carcinoma, normochromic normocytic anaemia. Tarceva dosage: 150 MG (QD) ORAL. During the same period patient was treated with CLARITHROMYCIN. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5728684-6
Tarceva side effect was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Apr 15, 2008. Male patient, 57 years of age, was diagnosed with metastases to central nervous system and was treated with Tarceva. After drug was administered, patient experienced the following side effects: computerised tomogram abnormal, convulsion, depressed level of consciousness, leukocytosis, malignant neoplasm progression, metastases to central nervous system, pyrexia, radiation skin injury, sepsis . Tarceva dosage: (150 MG, QD). During the same period patient was treated with GEFITINIB. Patient died on 01/06/2007.

Tarceva Side Effects Report #4899508-4
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 16, 2005. Male patient, 88 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression. Tarceva dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient died.

Tarceva Side Effects Report #4899479-0
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Oct 07, 2005. Female patient, 76 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with PANTOPRAZOLE, THYROID. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #5074862-1
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2006. Male patient, 71 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression. Tarceva dosage: 150 MG (QD),ORAL. Patient died on 01/31/2006.

Tarceva Side Effects Report #5073328-2
Tarceva side effect was reported by a Physician from UNITED STATES on Jan 27, 2006. Female patient, 66 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, retinal haemorrhage. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.

Tarceva Side Effects Report #5261430-1
Tarceva side effect was reported by a Physician from FRANCE on Feb 20, 2007. Female patient, 64 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: confusional state, lung neoplasm malignant, malignant neoplasm progression, vascular encephalopathy. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.

Tarceva Side Effects Report #5158844-7
Tarceva side effect was reported by a Physician from ARGENTINA on Nov 03, 2006. Male patient, 64 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: kidney infection, lung infection, lung neoplasm malignant, malignant neoplasm progression. Tarceva dosage: 100 MG, ORAL. Patient was hospitalized. Patient died.


Tarceva Side Effects Report #5954652-5
Tarceva side effect was reported by a Physician from FRANCE on Oct 30, 2008. Male patient, 64 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, epistaxis, jaundice , lung cancer metastatic, lymphangiosis carcinomatosa, malignant neoplasm progression, nausea , prothrombin time prolonged. Tarceva dosage: (150 MG, QD), ORAL. During the same period patient was treated with LOVENOX, PREDNISONE, CLASTOBAN, INIPOMP. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #6128105-8
Tarceva side effect was reported by a Consumer or non-health professional from GERMANY on Mar 04, 2009. Male patient, 63 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia , rash . Tarceva dosage: unknown. Patient died on 12/07/2008.

Tarceva Side Effects Report #5670188-3
Tarceva side effect was reported by a Physician from NETHERLANDS on Feb 27, 2008. Female patient, 62 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: alopecia, bronchial obstruction, cerebellar haemorrhage, cerebral haemorrhage, cerebral ischaemia, haemoptysis, malignant neoplasm progression, metastases to central nervous system, non-small cell lung cancer metastatic. Tarceva dosage: 150 MG, QD, ORAL. During the same period patient was treated with PREDNISONE, TEMAZEPAM. Patient was hospitalized. Patient died on 01/17/2008.

Tarceva Side Effects Report #5828427-1
Tarceva side effect was reported by a Health Professional from CANADA on July 15, 2008. Male patient, 60 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression. Tarceva dosage: (150 MG, QD), ORAL. Patient died on 06/04/2008.

Tarceva Side Effects Report #5423121-3
Tarceva side effect was reported by a Physician from BRAZIL on Aug 06, 2007. Male patient, 57 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemothorax, interstitial lung disease, lung neoplasm malignant, malignant neoplasm progression, no therapeutic response, pleural haemorrhage. Tarceva dosage: 150 MG (QD),ORAL. Patient was hospitalized. Patient died on 07/22/2007.

Tarceva Side Effects Report #5113404-9
Tarceva side effect was reported by a Health Professional from SWEDEN on Sept 05, 2006. Female patient, 56 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cough, diarrhoea, dyspnoea, infection in an immunocompromised host, lung neoplasm malignant, malignant neoplasm progression, respiratory tract infection. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with OXIS TURBUHALER, ATACAND, EMCONCOR, KESTINE, OMEPRAZOLE, AREDIA, ACETAMINOPHEN. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #5472454-3
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Sept 11, 2007. Female patient, 55 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression, platelet count decreased, respiratory failure, white blood cell count decreased. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with PROPOXYPHEN NAPSYLATE, ZOLPIDEM TARTRATE, DILANTIN KAPSEAL, MANNITOL. Patient died on 08/31/2007.

Tarceva Side Effects Report #4899439-X
Tarceva side effect was reported by a Health Professional from UNITED STATES on June 08, 2005. Female patient, 54 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: alopecia, disease progression, malignant neoplasm progression. Tarceva dosage: 150 MG (QD) ORAL. Patient recovered.

Tarceva Side Effects Report #5255361-0
Tarceva side effect was reported by a Physician from FRANCE on Feb 14, 2007. Male patient was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: chest pain , lung neoplasm malignant, malignant neoplasm progression. Tarceva dosage: unknown. Patient died.

Tarceva Side Effects Report #5930591-0
Tarceva side effect was reported by a Consumer or non-health professional from NEW ZEALAND on Oct 06, 2008. Male patient was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: brain neoplasm, haemorrhage, hemiparesis, insomnia, malignant neoplasm progression, ulcer . Tarceva dosage: (150 MG, QD), ORAL. During the same period patient was treated with OMEPRAZOLE. Patient was hospitalized. Patient recovered.


Tarceva Side Effects Report #6016565-2
Tarceva side effect was reported by a Physician from FINLAND on Dec 03, 2008. Female patient, 68 years of age, was diagnosed with lung cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: atelectasis, diarrhoea, lung infiltration, malignant neoplasm progression, petechiae, pleural effusion, rash , social problem. Tarceva dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5809640-6
Tarceva side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on June 24, 2008. Male patient was diagnosed with lung cancer metastatic, lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: humerus fracture, interstitial lung disease, malignant neoplasm progression, metastasis. Tarceva dosage: unknown. During the same period patient was treated with BEVACIZUMAB, IRESSA. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5088392-4
Tarceva side effect was reported by a Physician from UNITED STATES on July 12, 2006. Female patient, 81 years of age, was diagnosed with lung adenocarcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: deafness, fatigue, malignant neoplasm progression, rash . Tarceva dosage: unknown. Patient died.

Tarceva Side Effects Report #5884688-4
Tarceva side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 27, 2008. Male patient, 50 years of age, was diagnosed with lung adenocarcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: interstitial lung disease, malignant neoplasm progression, quality of life decreased, rash , respiratory failure. Tarceva dosage: (150 MG, QD), ORAL. During the same period patient was treated with MECLIZINE, MOSAPRIDE CITRATE, BROWNTURE. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #5166558-2
Tarceva side effect was reported by a Physician from FINLAND on Nov 13, 2006. Female patient, 61 years of age, was diagnosed with gastric cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: carcinoembryonic antigen increased, gastric cancer, intracranial venous sinus thrombosis, malignant neoplasm progression, nervous system disorder, neurological symptom, pyrexia. Tarceva dosage: 500 MG (Q 36 HOURS), ORAL. During the same period patient was treated with AVASTIN, DOCETAXEL, IRINOTECAN. Patient died on 02/07/2006.

Tarceva Side Effects Report #4952909-8
Tarceva side effect was reported by a Physician from FINLAND on Mar 06, 2006. Female patient, 55 years of age, was diagnosed with gastric cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: intracranial pressure increased, intracranial venous sinus thrombosis, malignant neoplasm progression. Tarceva dosage: unknown. During the same period patient was treated with AVASTIN, IRINOTECAN, DOCETAXEL. Patient died on 02/07/2006.

Tarceva Side Effects Report #6084765-1
Tarceva side effect was reported by a Physician from FRANCE on Feb 02, 2009. Male patient, 49 years of age, was diagnosed with bronchial carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: convulsion, fatigue, malignant neoplasm progression, metastases to central nervous system, nausea . Tarceva dosage: (150 MG, QD), ORAL. During the same period patient was treated with INIPOMP, PREGABALIN. Patient recovered.

Tarceva Side Effects Report #5015938-4
Tarceva side effect was reported by a Health Professional from UNITED STATES on May 31, 2006. Female patient, 64 years of age, was diagnosed with breast cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: balance disorder, chromaturia, cognitive disorder, diarrhoea, faeces discoloured, jaundice , malignant neoplasm progression, metastases to liver, nausea . Tarceva dosage: 100 MG PO QD. During the same period patient was treated with RADOO, HYZAAR, ZOCOR, LEXAPRO, ASPIRIN, ATIVAN, COMPAZINE, ZOFRAN. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5532946-5
Tarceva side effect was reported by a Physician from UNITED STATES on Nov 14, 2007. Female patient, 45 years of age, weighting 142.3 lb, was diagnosed with adenocarcinoma pancreas and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cardiomyopathy , ejection fraction decreased, malignant neoplasm progression, nausea , oedema peripheral, ventricular tachycardia. Tarceva dosage: 100 MG, ORAL. During the same period patient was treated with TAXOTERE, SALBUTAMOL, MEGACE, MIRALAX, REGLAN, PROCHLOPERAZINE, DEXAMETHASONE, PALONOSETRON. Patient was hospitalized. Patient died.

Tarceva Side Effects Report #6079788-2
Tarceva side effect was reported by a Physician from UNITED KINGDOM on Jan 28, 2009. Female patient, 35 years of age, was diagnosed with adenocarcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: bile duct cancer, condition aggravated, convulsion, malignant neoplasm progression, no therapeutic response. Tarceva dosage: 50 MG, QD, ORAL. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, TAXOTERE, VALPROATE, DEXAMETHASONE, KEPPRA. Patient was hospitalized and became disabled. Patient died.


Tarceva Side Effects Report #4958302-6
Tarceva side effect was reported by a Consumer or non-health professional from CANADA on Mar 10, 2006. Female patient, 83 years of age, was treated with Tarceva. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, non-small cell lung cancer. Tarceva dosage: 150 MG (QD), ORAL. Patient died.

Tarceva Side Effects Report #5512594-3
Tarceva side effect was reported by a Physician from NETHERLANDS on Oct 22, 2007. Female patient, 73 years of age, was treated with Tarceva. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to central nervous system, skin ulcer. Tarceva dosage: unknown. Patient died.

Tarceva Side Effects Report #5067875-7
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 23, 2005. Male patient was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, erythema, malignant neoplasm progression. Tarceva dosage: unknown. Patient died.

Tarceva Side Effects Report #6009923-3
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Nov 25, 2008. Female patient was treated with Tarceva. After drug was administered, patient experienced the following side effects: dysphagia, malignant neoplasm progression. Tarceva dosage: unknown. Patient was hospitalized. Patient died.